CP-4055
Term · Oncology and biomedicine · MLC-T-ONC-002110
A drug used to treat advanced acute myeloid leukemia (AML). It is a form of the anticancer drug cytarabine that may work in patients with leukemia that is resistant to cytarabine. CP-4055 blocks cell division and may kill cancer cells. It is a type of antimetabolite. Also called Elacyt and elacytarabine.
| Identifier | MLC-T-ONC-002110 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Elacyt; elacytarabine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002110",
"term": "CP-4055",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat advanced acute myeloid leukemia (AML). It is a form of the anticancer drug cytarabine that may work in patients with leukemia that is resistant to cytarabine. CP-4055 blocks cell division and may kill cancer cells. It is a type of antimetabolite. Also called Elacyt and elacytarabine.",
"expansions": [
"Elacyt",
"elacytarabine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cp-4055/"
}
Record 5,389 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.